Results (4016)


Fin-CARING2
Finland
First published:
02/07/2024
Data source
Cancer registryHospital discharge recordsPharmacy dispensing records
Non-interventional post-authorization effectiveness study to assess long-term outcomes of Nintedanib treatment in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD) (Nintedanib long-term outcomes in patients with SSc)
Argentina
Armenia
Austria
Belgium
Brazil
Bulgaria
Canada
China
Croatia
Czechia
Denmark
Dominican Republic
Egypt
Estonia
Finland
France
Germany
Greece
Hungary
Iran, Islamic Republic of
Ireland
Israel
Italy
Japan
Lithuania
Malta
Moldova, Republic of
Montenegro
Netherlands
New Zealand
Norway
Poland
Portugal
Romania
Russian Federation
Serbia
Slovenia
South Africa
Spain
Sweden
Switzerland
Türkiye
Ukraine
United Kingdom
United States
EU PAS number:
EUPAS106792
First published:
02/07/2024
StudyPlanned
Observational Safety Data Analysis from Routine Follow-up in the EuroSIDA Study of Patients Treated with Raltegravir in a Five-Year Post Authorization Period (MK-0518-058)
Argentina
Austria
Belarus
Belgium
Bulgaria
Croatia
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Israel
Italy
Latvia
Lithuania
Luxembourg
Netherlands
Norway
Poland
Portugal
Romania
Russian Federation
Serbia
Slovakia
Spain
Sweden
Switzerland
Ukraine
United Kingdom
EU PAS number:
EUPAS17912
First published:
02/07/2024
StudyFinalised